Enzy-D Tablet is a combination pharmaceutical formulation containing Trypsin (48mg), Bromelain (90mg), Rutoside (100mg), and Diclofenac (50mg), designed to provide effective anti-inflammatory, analgesic, and proteolytic enzyme therapy. Trypsin and Bromelain are proteolytic enzymes that facilitate the breakdown of proteins, promoting the reduction of edema and inflammation by enhancing the absorption of inflammatory exudates. Rutoside, a bioflavonoid, acts as a vascular protector by strengthening capillary walls and reducing capillary permeability, thereby minimizing bruising and swelling. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), provides potent analgesic and anti-inflammatory effects by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased synthesis of prostaglandins responsible for pain and inflammation. The synergistic action of these components makes Enzy-D Tablet suitable for managing acute musculoskeletal conditions such as sprains, strains, contusions, and postoperative inflammation. It is indicated for the relief of pain, swelling, and inflammation associated with trauma or surgical interventions. Enzy-D Tablet should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, or bleeding disorders. Adherence to prescribed dosage and monitoring for adverse effects is essential to ensure safety and therapeutic efficacy.